World Journal of
Pharmaceutical and Life Sciences

COVID 19: A RE-EMERGING PUBLIC HEALTH CHALLENGE

*Sumit Kailas Musale, Shweta Shamrao Dhavane, Rinku Mukund Bhavsar and Ankita Vitthalrao Bhosale

ABSTRACT

The corona virus is named as a COVID-19 (Co-corona, vi-Virus, d-Disease), which is easily transmitted from person to person. The main symptoms of corona virus is sore throat, Runny nose, Headache, Difficulty in breathing, etc. The corona virus majorly affects the respiratory system and cardiovascular system. Corona viruses (CoVs) are a large family of viruses that causes illness ranging from the common cold to more sever disease such as Middle East Respiratory (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel corona virus (nCoV) is a new strain that has not been previously identified in humans. Corona viruses are zoonotic, meaning they are transmitted between animals and people. Corona viruses are large, enveloped, positive-stranded RNA viruses. They are the largest genome among all RNA viruses. The corona viruses spread from person to person among close contacts. Currently, there is no specific medicine or vaccine for COVID-19 and no medicines vaccines have been fully tested for safety and efficacy. At present, antiviral therapy is mainly used, as well as symptomatic and supportive treatment based on clinical condition of the patient. Avoid the meeting to infected person, leave from the infected area are the some measures to control the viral infection.

[Full Text Article]   [Download Certificate]